Critical Care

official impact factor 4.60

Viewpoint

Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?

Moritoki Egi, Rinaldo Bellomo* and Michael C Reade

Critical Care 2009, 13:302 doi:10.1186/cc7755

No comments have yet been made on this article.

Post a comment